HTGC

NYSE: HTGC (Stock Quote) $13.39 $-0.10 -0.74%
NYSE: HTGZ (Bond Quote) $25.98 $-0.06 -0.23%
NYSE: HTGY (Bond Quote) $25.63 $-0.21 -0.81%
  • Company
    • Investment Focus
    • Financing Solutions
      • Technology
      • Cleantech
      • Life Science
      • Special-Opportunity Lower Middle Market
    • Venture Capital & Private Equity
    • Giving Back to the Community
    • Careers
  • Team
    • Investment Professionals
      • Technology
      • Cleantech
      • Life Science
      • Special-Opportunity Lower Middle Market
    • Management
    • Board of Directors
    • Team A-Z
  • Portfolio
    • Technology
    • Cleantech
    • Life Science
    • Special-Opportunity Lower Middle Market
    • Exit History
    • A-Z Portfolio List
  • Investor Relations
    • News & Events
      • Press Releases
      • Webcasts & Events
    • Financials & Filings
      • Analyst Coverage
      • Annual Reports
      • Dividends
        • Dividend Reinvestment Plan
      • Financial Statements
      • Quarterly Results
      • SEC Filings
      • Stock Information
        • Stock Performance
        • Historic Stock Lookup
        • Calculator
      • Tax Information
      • Email Alert Subscription
    • Corporate Governance
      • Corporate Governance Guidelines
      • Audit Committee
      • Compensation Comittee
      • Insider Ownership
      • Insider Transactions
    • Company Information
      • Company Information
      • Executive Management
      • Investor FAQs
      • IR Contact
      • Major Shareholders
    • Credit Ratings
    • What is a BDC
    • Shareholder Tools
      • Investor Briefcase
      • Download Library
      • Printed Materials
      • RSS News Feeds
  • News & Events
    • Press Releases
    • Hercules in the News
    • Portfolio Company News
    • Webcast & Events
  • Venture Debt
  • Contact

Exit History

Hercules has a track record of supporting its companies through various cycles of growth. Growth is seldom a straight line so it is important to work with a lender that both understands the inherent challenges of building a business and also has the flexibility and long-term perspective to help entrepreneurs achieve market success.
  • Technology
  • CleanTech
  • Life Science
  • Special-Opportunity Lower Middle Market
  • Exit History
  • A-Z Portfolio List
Home » Portfolio » Exit History


Adiana
Aegerion
Pharmaceuticals
Affinity
VideoNet
Affinity Express
Agami Systems
Ageia
Technologies
Althea
Technologies
Annie's
Aveo
Pharmaceuticals
BARRx
Bullhorn
Cempra, Inc
Compete
Cornice
Crux Biomedical
deCODE Genetics
Diomed Holdings
Enphase Energy
facebook
GameLogic
Gomez
Guava
Technologies
Horizon
Therapeutics
InfoLogix
Intelliden
Interwise
Inxight Software
LaboPharm
Merrimack
Pharmaceuticals
NextWave
Pharmaceuticals
NEXX Systems
OATSystems
Occam Networks
Omrix
Biopharmaceuticals
Omthera
Pharmaceuticals, Inc.
OpSource
Optovia
Pacira
Pharmaceuticals
Pathfire
PSS Systems
Rivulet
Communications
Rubicon
Technology
Savvion
Sirtris
Pharmaceuticals
Sling Media
Talisma
Transcept
Pharmaceuticals
Trulia
VeriWave
Votizen
WageWorks

© 2013 Hercules Technology Growth Capital. All rights reserved. Problems with the site? Email webmaster@htgc.com
Terms of Use & Privacy Policy
*Historical, intraday and current end-of-day data provided by eSignal. Intraday data is at least 20-minutes delayed.